Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
β Scribed by Sandborn, William J.; Gasink, Christopher; Gao, Long-Long; Blank, Marion A.; Johanns, Jewel; Guzzo, Cynthia; Sands, Bruce E.; Hanauer, Stephen B.; Targan, Stephan; Rutgeerts, Paul; Ghosh, Subrata; de Villiers, Willem J.S.; Panaccione, Remo; Greenberg, Gordon; Schreiber, Stefan; Lichtiger, Simon; Feagan, Brian G.
- Book ID
- 115534031
- Publisher
- Massachusetts Medical Society
- Year
- 2012
- Tongue
- English
- Weight
- 596 KB
- Volume
- 367
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: There is no standard approach for the medical management of Crohn's disease (CD) during pregnancy and there is limited data regarding safety and efficacy of the treatments. Budesonide (Entocort EC, AstraZeneca) is an enteric coated locally acting glucocorticoid preparation whose pH-and t